The safety of febuxostat versus allopurinol in gout patients with hyperuricemia.

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: CHEN, Jungyi (Kaohsiung Veterans General Hospital, Tainan City, China Taiwan)
  • Co-author(s): Jungyi Chen
  • Abstract:


    All randomized control trials which reported the safety data in comparing Febuxostat to Allopurinol were included. Then, a systematic review and meta-analysis was performed to get the pooled risk ratio of all side effects and abnormal liver function.


    Eight randomized controlled trials were included for systematic review and


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login